SciCombinator

Discover the most talked about and latest scientific content & concepts.

Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 16 Feb 2018

C Ozgonul, VS Dedania and CG Besirli
Abstract
To compare functional and anatomic outcomes of treatment with intravitreal aflibercept versus bevacizumab and/or ranibizumab in patients with recurrent macular edema (ME) secondary to central retinal vein occlusion (CRVO).
Tweets*
0
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
Central retinal vein occlusion, Central retinal vein, Macular degeneration
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com